Koliakos G G, Kouzi-Koliakos K, Furcht L T, Reger L A, Tsilibary E C
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455.
J Biol Chem. 1989 Feb 5;264(4):2313-23.
Three distinctive heparin-binding sites were observed in type IV collagen by the use of rotary shadowing: in the NC1 domain and at distances 100 and 300 nm from the NC1 domain. Scatchard analysis indicated different affinities for these sites. Electron microscopic analysis of heparin-type IV collagen interaction with increasing salt concentrations showed the different affinities to be NC1 greater than 100 nm greater than 300 nm. The NC1 domain bound specifically to chondroitin/dermatan sulfate side chains as well. This binding was observed at the electron microscope and in solid-phase binding assays (where chondroitin sulfate could compete for the binding of [3H]heparin to NC1-coated substrata). The triple helix-rich, rod-like domain of type IV collagen did not bind to chondroitin/dermatan sulfate side chains. In solid-phase binding assays only heparin could compete for the binding of [3H]heparin to this domain. In order to more precisely map potential heparin-binding sites in type IV collagen, we chemically synthesized 17 arginine- and lysine-containing peptides from the alpha 1(IV) and alpha 2(IV) chains. Three peptides from the known sequence of the alpha 1(IV) and alpha 2(IV) chains were shown to specifically bind heparin: peptide Hep-I (TAGSCLRKFSTM), from the alpha 1(NC1) chain, peptide Hep-II (LAGSCLARFSTM), a peptide corresponding to the same sequence in peptide Hep-I from the alpha 2 (NC1) chain, and peptide Hep-III (GEFYFDLRLKGDK) which contained an interruption of the triple helical sequence of the alpha 1(IV) chain at about 300 nm from the NC1 domain, were demonstrated to bind heparin in solid-phase binding assays and compete for the binding of [3H]heparin to type IV collagen-coated substrata. Therefore, each of these peptides may represent a potential heparin-binding site in type IV collagen. The mapping of the binding of heparin or related structures, such as heparan sulfate proteoglycan, to specific sequences of type IV collagen could help the understanding of several structural and functional properties of this basement membrane protein as well as interactions with other basement membrane and/or cell surface-associated macromolecules.
通过旋转投影法在IV型胶原中观察到三个不同的肝素结合位点:一个在NC1结构域,另外两个分别距NC1结构域100纳米和300纳米处。Scatchard分析表明这些位点具有不同的亲和力。对肝素与IV型胶原相互作用随盐浓度增加的电子显微镜分析显示,亲和力大小顺序为:NC1结构域>100纳米处位点>300纳米处位点。NC1结构域还能特异性结合硫酸软骨素/硫酸皮肤素侧链。在电子显微镜下以及固相结合试验中均观察到这种结合(在固相结合试验中,硫酸软骨素可竞争[3H]肝素与包被有NC1的基质的结合)。IV型胶原富含三股螺旋的杆状结构域不与硫酸软骨素/硫酸皮肤素侧链结合。在固相结合试验中,只有肝素能竞争[3H]肝素与该结构域的结合。为了更精确地定位IV型胶原中潜在的肝素结合位点,我们从α1(IV)链和α2(IV)链化学合成了17种含精氨酸和赖氨酸的肽段。已证明来自α1(IV)链和α2(IV)链已知序列的三种肽段能特异性结合肝素:来自α1(NC1)链的肽段Hep-I(TAGSCLRKFSTM)、来自α2(NC1)链且与肽段Hep-I相同序列对应的肽段Hep-II(LAGSCLARFSTM),以及肽段Hep-III(GEFYFDLRLKGDK),该肽段在距NC1结构域约300纳米处含有α1(IV)链三股螺旋序列的中断部分,在固相结合试验中证明其能结合肝素,并竞争[3H]肝素与包被有IV型胶原的基质的结合。因此,这些肽段中的每一个都可能代表IV型胶原中一个潜在的肝素结合位点。绘制肝素或相关结构(如硫酸乙酰肝素蛋白聚糖)与IV型胶原特定序列的结合图谱,有助于理解这种基底膜蛋白的多种结构和功能特性,以及其与其他基底膜和/或细胞表面相关大分子的相互作用。